ALL >> General >> View Article
Rznomics: Circular Rna Platform Tech
![Profile Picture](https://www.123articleonline.com/images/avatar-default.jpg)
Rznomics, a biopharmaceutical company, has developed a groundbreaking 'self-circularized RNA structure' platform technology that efficiently generates circular RNA, overcoming the limitations of existing methods.
Circular RNA (circRNA) offers improved stability against nucleases and minimal unwanted immune responses, making it an attractive candidate for vaccines and therapeutics. Rznomics' technology utilizes a unique Tetrahymena trans-splicing ribozyme platform to convert linear RNA into circular RNA through an end-to-end self-targeting and splicing (STS) reaction. Unlike other methods, Rznomics' circularization does not leave unnecessary genetic information in the gene of interest (GOI). The efficiency of the self-circularization process is comparable to other methods, and various optimization strategies can be employed to increase its efficacy, even with long RNA molecules.
The significance of Rznomics' technology lies in its potential for commercialization, enabling more competitive pricing for circRNA vaccines or therapeutics while maintaining efficacy. In vitro transcription initiates the self-circularization ...
... reaction simultaneously, streamlining the purification process. The purified circRNA demonstrates sustained protein expression without unwanted immune responses, outperforming linear RNA with modified nucleotides.
The research was supported by the Ministry of Science & ICT and the National Research Foundation of Korea. Rznomics holds a patent for the 'Self-circularization RNA structure and Platform technology' in South Korea, with applications submitted in the U.S. and other major countries.
Rznomics is a biopharmaceutical company focused on RNA-based gene therapeutic bio-drugs for cancer and incurable diseases. Their core platform technology utilizes an RNA replacement enzyme, trans-splicing ribozyme, to selectively induce therapeutic gene activity in cells expressing target RNA. The company's lead candidate, RZ-001, is intended for treating Hepatocellular Carcinoma & Glioblastoma, with other treatments in the pipeline for Alzheimer's disease and hereditary retinal dystrophy.
More Information : https://www.techdogs.com/tech-news/pr-newswire/rznomics-presents-its-own-circular-rna-platform-technology
Add Comment
General Articles
1. Best Discount For All Types Of Website & Digital Marketing Services | BrsAuthor: Brand Roof Solutions
2. Discover Duplex Homes In Hyderabad: Your Ideal Match
Author: Mirchi Developers
3. Personalized Pendants, Bracelets, Rings, And Chains Unique Groomsmen Gifts
Author: Andrew Wilson
4. How To Get Nonstop Flight Deals? | Tips And Tricks
Author: we love travel
5. Role Of Social Media In Building Effective Customer Relationships
Author: Mana Projects
6. Why Avya Farms Offers The Best Agricultural Land Near Bangalore
Author: Mana Projects
7. Why Luxury Villas For Sale In Varthur, Bangalore Are Ideal For Families
Author: Mana Projects
8. Exploring Apartments Near Sarjapur Road, Bangalore For A Perfect Urban Lifestyle
Author: Mana Projects
9. Experience Opulence: 4 Bhk Premium Flats For Sale In Sarjapur Road
Author: Mana Projects
10. Behind The Scenes: How Perfumes Are Made
Author: ash
11. Personal Loans Apply In North 24 Parganas (west Bengal)
Author: Angel group Finance
12. Personal Loan And Business Loans In Haldia: A Comprehensive Guide
Author: Angel group Finance
13. Urgent Cash Loans In Kolkata
Author: Angel group
14. Low Price Good Quality Pcd Franchise
Author: elkosgroup
15. Titanium Gr 9 Pipes & Tubes In India
Author: GirishVyas